9dca4f01-figure-01 (Azacitidine 1)
Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 68001-313
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 68001-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
9dca4f01-figure-02 (Azacitidine 2)
The text appears to be a statistical analysis report displaying survival data for two groups (AZA and CCR) with respect to time. The Log-Rank value is 0.0001 and hazard ratio is 0.58. The number of deaths for AZA and CCR were 82 and 113, respectively. The rest of the information suggests graphical representation of survival curves for both groups over the observed time period.*
Azacitidine Carton Rev 04-17 (Azacitidine 3)
This appears to be a label of a medication called "Azacitidine". It is a cytotoxic agent used in injection form for subcutaneous or intravenous use. The label provides information on dosage, storage, and reconstitution of the medication. The text also mentions that the medication is kept as a lyophilized powder.*
Azacitidine Inj_100mg_rev 09-16_bluepoint Label (Approved)
This text contains information about a medication called Azacitidine. Each vial of medication contains 100 mg of Azacitidine along with other ingredients like sucrose, monosodium phosphate monohydrate, and disodium hydrogen phosphate dihydrate. The medication is intended for use by prescription only, and the recommended dosage should be followed as per the prescribing information. The unreconstituted vials should be stored at a temperature of 25°C while for injection, the temperature range permitted is between 15° to 30°C. The medication's brand name is Sindan Pharma SR FoF, produced in Romania by lyophilized powder. It is used for subcutaneous use and intravenous infusion at the discretion of the healthcare professional. It is sterile, nonpyrogenic, and preservative-free. It is a "Cytotoxic Agent," meaning that it is a substance that has toxic effects on living cells. The medication is available in a blue single-dose file, and it comes with a caution to discard any unused portion of the medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
